QNTM
Quantum BioPharma Ltd.
NASDAQ: QNTM · HEALTHCARE · BIOTECHNOLOGY
$5.20
-4.91% today
Updated 2026-06-05
Market cap
$25.15M
P/E ratio
—
P/S ratio
91.86x
EPS (TTM)
$-7.73
Dividend yield
—
52W range
$2 – $38
Volume
0.5M
Quantum BioPharma Ltd. (QNTM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-2,057.00%
ROA
-62.40%
Debt/equity
1.46x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | — | $-32800.00 | — | — | — |
| 2016 | — | $-29628.00 | — | — | — |
| 2017 | $20630.00 | $-2.80M | 100.00% | -13,586.02% | -13,586.02% |
| 2018 | — | $-16.67M | — | — | — |
| 2019 | — | $-39.13M | — | — | — |
| 2020 | $0.00 | $-31.80M | — | — | — |
| 2021 | $0.00 | $-35.29M | — | — | — |
| 2022 | $0.00 | $-23.61M | — | — | — |
| 2023 | $0.00 | $-17.90M | — | — | — |
| 2024 | $0.00 | $-14.20M | — | — | — |
| 2025 | $0.00 | $-26.18M | — | — | — |
Frequently asked questions
How much free cash flow does QNTM generate?
QNTM produced $-8.38M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is QNTM's balance sheet healthy?
QNTM holds $1.90M in cash and equivalents against — in long-term debt, on $6.91M of shareholder equity. That debt is best read against the cash flow the business throws off each year.